In Vivo Characterization of Phosphotransferase-Encoding Genes istP and forP as Interchangeable Launchers of the C3’,4’-Dideoxygenation Biosynthetic Pathway of 1,4-Diaminocyclitol Antibiotics
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Deactivation of aminoglycosides by their modifying enzymes, including a number of aminoglycoside O-phosphotransferases, is the most ubiquitous resistance mechanism in aminoglycoside-resistant pathogens. Nonetheless, in a couple of biosynthetic pathways for gentamicins, fortimicins, and istamycins, phosphorylation of aminoglycosides seems to be a unique and initial step for the creation of a natural defensive structural feature such as a 3’,4’- dideoxy scaffold. Our aim was to elucidate the biochemical details on the beginning of these C3’,4’-dideoxygenation biosynthetic steps for aminoglycosides. The biosynthesis of istamycins must surely involve these 3’,4’-didehydroxylation steps, but much less has been reported in terms of characterization of istamycin biosynthetic genes, especially about the phosphotransferase-encoding gene. In the disruption and complementation experiments pointing to a putative gene, istP, in the genome of wild-type Streptomyces tenjimariensis, the function of the istP gene was proved here to be a phosphotransferase. Next, an in-frame deletion of a known phosphotransferase-encoding gene forP from the genome of wild-type Micromonospora olivasterospora resulted in the appearance of a hitherto unidentified fortimicin shunt product, namely 3-O-methyl-FOR-KK1, whereas complementation of forP restored the natural fortimicin metabolite profiles. The bilateral complementation of an istP gene (or forP) in the ΔforP mutant (or ΔistP mutant strain) successfully restored the biosynthesis of 3’,4’- dideoxy fortimicins and istamycins, thus clearly indicating that they are interchangeable launchers of the biosynthesis of 3’,4’-dideoxy types of 1,4-diaminocyclitol antibiotics.
Abstract
Deactivation of aminoglycosides by their modifying enzymes, including a number of aminoglycoside O-phosphotransferases, is the most ubiquitous resistance mechanism in aminoglycoside-resistant pathogens. Nonetheless, in a couple of biosynthetic pathways for gentamicins, fortimicins, and istamycins, phosphorylation of aminoglycosides seems to be a unique and initial step for the creation of a natural defensive structural feature such as a 3’,4’- dideoxy scaffold. Our aim was to elucidate the biochemical details on the beginning of these C3’,4’-dideoxygenation biosynthetic steps for aminoglycosides. The biosynthesis of istamycins must surely involve these 3’,4’-didehydroxylation steps, but much less has been reported in terms of characterization of istamycin biosynthetic genes, especially about the phosphotransferase-encoding gene. In the disruption and complementation experiments pointing to a putative gene, istP, in the genome of wild-type Streptomyces tenjimariensis, the function of the istP gene was proved here to be a phosphotransferase. Next, an in-frame deletion of a known phosphotransferase-encoding gene forP from the genome of wild-type Micromonospora olivasterospora resulted in the appearance of a hitherto unidentified fortimicin shunt product, namely 3-O-methyl-FOR-KK1, whereas complementation of forP restored the natural fortimicin metabolite profiles. The bilateral complementation of an istP gene (or forP) in the ΔforP mutant (or ΔistP mutant strain) successfully restored the biosynthesis of 3’,4’- dideoxy fortimicins and istamycins, thus clearly indicating that they are interchangeable launchers of the biosynthesis of 3’,4’-dideoxy types of 1,4-diaminocyclitol antibiotics.
참고문헌 (15)
- Park SR, "2-Deoxystreptamine-containing aminoglycoside antibiotics : recent advances in the characterization and manipulation of their biosynthetic pathways", Nat. Prod. Rep, 30, pp.11~20 (2013)
- Pokrovskaya V, "Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases", Methods Enzymol, 478, pp.437~462 (2010)
- Park JW, "Enabling techniques in the search for new antibiotics : combinatorial biosynthesis of sugar-containing antibiotics", Biochem. Pharmacol, 134, pp.56~73 (2017)
- Yamamoto M, "Fortimicin A production by Micromonospora olivoasterospora in a chemically defined medium", J, Antibiot. (Tokyo), 30, pp.1064~1072 (1977)
- Ikeda D, "Synthesis of istamycin A", J. Antibiot. (Tokyo), 32, pp.1365~1366 (1979)
- Matsuhashi Y, "In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics, Antimicrob", Agents Chemother, 27, pp.589~594 (1985)
- Ramirez MS, "Aminoglycoside modifying enzymes", Drug Resist. Updat, 13, pp.151~171 (2010)
- Park JW, "Biosynthetic pathways of aminoglycosides and their engineering", Curr. Opin. Biotechnol, 48, pp.33~41 (2017)
- Dairi T, "Organization and nature of fortimicin A(astromicin)biosynthetic genes studied using a cosmid library of Micromonospora olivasterospora DNA", Mol. Gen. Genet, 236, pp.39~48 (1992)
- Shao L, "Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis", Bioorg. Med. Chem. Lett, 23, pp.1438~1441 (2013)
- Li S, "Methyltransferases of gentamicin biosynthesis", Proc. Natl. Acad. Sci. USA, 115, pp.1340~1345 (2018)
- MacNeil DJ, "Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector", Gene, 111, pp.61~68 (1992)
- Hoang NH, "Istamycin aminoglycosides profiling and their characterization in Streptomyces tenjimariensis ATCC 31603culture using high-performance liquid chromatography with tandem mass spectrometry", J. Sep. Sci, 39, pp.4712~4722 (2016)
- Park JW, "Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation", Nat, Chem. Biol, 7, pp.843~852 (2011)
- Huong NL, "Characterization of fortimicin aminoglycoside profiles produced from Micromonospora olivasterospora DSM 43868 by high-performance liquid chromatography-electrospray ionization-ion trap-mass spectrometry", Anal. Bioanal. Chem, 408, pp.1667~1678 (2016)